CPCB-RPE1 for Macular Degeneration

"Unfortunately, the information on clinicaltrials.gov appears to show that this particular trial is not actively seeking participants at this time; it was first posted in February of 2016 and last updated May 27th 2020. Nevertheless, there are currently 319 other studies available for enrollment."

"Currently, this research initiative is accepting patients from 6 medical sites. These are located in Santa Barbara, Beverly Hills and Palm Desert among other areas. To minimize travelling demands associated with joining the trial, pick a study location that is closest to you."

"The requirements for this medical trial are that patients must be between 55 and 85 years of age. For those under 18, there are 51 trials available; whereas 266 studies accept participants above the senior citizen threshold."

"This clinical trial is admitting 16 participants, aged 55 to 85, who have dry macular degeneration. To be eligible for the study, these individuals must also meet many other criteria including: having physical evidence of at least 1.25 square millimeters of geographic atrophy in their eye; not being employees of any related medical sites; possessing enough good health so as to reasonably expect survival over five years post-treatment; having a best-corrected visual acuity (BCVA) score equal or worse than 20/200 and between 20/80 and 20/400 in the second half of patients respectively; medically suitable for surgical implant procedures"